The transaction is expected to be modestly accretive to Omnicare’s earnings in 2008, with accretion expected to increase in 2009 and beyond.
Joel Gemunder, president and CEO of Omnicare, said: “The acquisition of Advanced Care Scripts is squarely in line with our strategy of broadening Omnicare’s platform through the addition of high-growth businesses as it enhances Omnicare’s position in specialty pharmaceutical services – one of the fastest growing sectors in pharmaceutical care.”